NCT02159066 2024-03-05
LOGIC-2
Pfizer
Phase 2 Completed
Clinical Trials
5 trialsNCT01928459 2020-12-09
Phase 1b Trial of BGJ398/BYL719 in Solid Tumors
Novartis
Phase 1 Completed
NCT01697605 2020-12-08
A Phase I Study of Oral BGJ398 in Asian Patients
Novartis
Phase 1 Completed
NCT01975701 2019-12-04
A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
Novartis
Phase 2 Completed
NCT01004224 2019-10-04
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Novartis
Phase 1 Completed